Your browser doesn't support javascript.
loading
A phase 1/2a safety, pharmacokinetics, and efficacy study of the novel nucleoside analog FF-10502-01 for the treatment of advanced solid tumors.
Janku, Filip; Javle, Milind M; Sen, Shiraj; Pant, Shubham; Bramwell, Lindsay G; Subbiah, Vivek; Way, Tracey; Wages, David S; Wheeler, Catherine A; Suzuki, Takeaki; Saeki, Kazunori; Subach, Ruth Ann; Madden, Timothy; Maier, Gary; Johansen, Mary J; Cheung, Kin; Falchook, Gerald S.
Afiliación
  • Janku F; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Javle MM; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Sen S; Sarah Cannon Research Institute at HealthONE, Denver, Colorado, USA.
  • Pant S; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Bramwell LG; Sarah Cannon Research Institute at HealthONE, Denver, Colorado, USA.
  • Subbiah V; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Way T; Sarah Cannon Research Institute at HealthONE, Denver, Colorado, USA.
  • Wages DS; FUJIFILM Pharmaceuticals U.S.A., Inc., Cambridge, Massachusetts, USA.
  • Wheeler CA; FUJIFILM Pharmaceuticals U.S.A., Inc., Cambridge, Massachusetts, USA.
  • Suzuki T; FUJIFILM Pharmaceuticals U.S.A., Inc., Cambridge, Massachusetts, USA.
  • Saeki K; FUJIFILM Corporation, Tokyo, Japan.
  • Subach RA; FUJIFILM Pharmaceuticals U.S.A., Inc., Cambridge, Massachusetts, USA.
  • Madden T; FUJIFILM Pharmaceuticals U.S.A., Inc., Cambridge, Massachusetts, USA.
  • Maier G; FUJIFILM Pharmaceuticals U.S.A., Inc., Cambridge, Massachusetts, USA.
  • Johansen MJ; FUJIFILM Pharmaceuticals U.S.A., Inc., Cambridge, Massachusetts, USA.
  • Cheung K; FUJIFILM Pharmaceuticals U.S.A., Inc., Cambridge, Massachusetts, USA.
  • Falchook GS; Sarah Cannon Research Institute at HealthONE, Denver, Colorado, USA.
Cancer ; 129(10): 1537-1546, 2023 05 15.
Article en En | MEDLINE | ID: mdl-36882377
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de los Conductos Biliares / Colangiocarcinoma / Neoplasias de la Vesícula Biliar Límite: Humans Idioma: En Revista: Cancer Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de los Conductos Biliares / Colangiocarcinoma / Neoplasias de la Vesícula Biliar Límite: Humans Idioma: En Revista: Cancer Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos